Vimarsana
Biggest News Aggregation in the World

Page 14 - Alacyclovir News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alacyclovir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alacyclovir Today - Breaking & Trending Today

FDA Expands Vemlidy Use to Adolescents With Chronic HBV - Vimarsana News

FDA Expands Vemlidy Use to Adolescents With Chronic HBV

The indication for the nucleoside analog reverse transcriptase inhibitor in children aged 12 years and older is based on safety and efficacy data from a placebo-controlled clinical trial.

Genital HSV Shedding Declines Rapidly in First Year Post Infection - Vimarsana News

Genital HSV Shedding Declines Rapidly in First Year Post Infection

The risk of shedding was higher in those with primary HSV infections, said researchers.

Gilead Profit Tops Expectations Despite Lower COVID Drug Sales, Outlook Raised - Vimarsana News

Gilead Profit Tops Expectations Despite Lower COVID Drug Sales, Outlook Raised

Gilead Sciences on Thursday posted a higher-than-expected third-quarter profit on the back of strong demand for its HIV and cancer drugs, which helped offset lower sales of its COVID-19 antiviral drug and acquisition expenses.

NIH to Test Pfizer's Paxlovid for Long COVID - Vimarsana News

NIH to Test Pfizer's Paxlovid for Long COVID

The National Institutes of Health's $1 billion RECOVER Initiative has picked Pfizer Inc's antiviral drug Paxlovid as the first treatment it will study in patients with long COVID, organizers of the study said on Thursday.

New Deep Dive Into Paxlovid Interactions With CVD Meds - Vimarsana News

New Deep Dive Into Paxlovid Interactions With CVD Meds

A new review paper tackles potential drug-drug interactions with the antiviral drug and today's most commonly prescribed cardiovascular drugs.